Results 211 to 220 of about 426,021 (349)

Global and Regional Temporal Changes in Cross‐Country Inequalities of Site‐Specific Osteoarthritis Burden, 1990 to 2021

open access: yesArthritis Care &Research, EarlyView.
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rates (ASYRs) for site‐specific OA across 204 countries and territories were obtained from the Global Burden of Diseases, Injuries, and ...
Haowei Chen   +14 more
wiley   +1 more source

Food Additives

open access: yesNIPPON SHOKUHIN KOGYO GAKKAISHI, 1985
Fergus M. Clydesdale   +1 more
openaire   +3 more sources

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

open access: yesArthritis Care &Research, EarlyView.
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry   +16 more
wiley   +1 more source

Food additives and contaminants: An update [PDF]

open access: bronze, 1986
Paul M. Newberne, Michael W. Conner
openalex   +1 more source

Safety evaluation of pea fibre concentrate (FIPEA) as food additive. [PDF]

open access: yesEFSA J
EFSA Panel on Food Additives and Flavourings (FAF)   +29 more
europepmc   +1 more source

Heterogeneity of Rheumatoid Arthritis–Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations With Disease Outcomes

open access: yesArthritis Care &Research, EarlyView.
Objective We aimed to identify unique disease trajectories within rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) based on longitudinal forced vital capacity (FVC) values and their associated clinical outcomes. Methods We performed a cohort study of RA‐ILD within the Veterans Health Administration from 1999 to 2021.
Bryant R. England   +9 more
wiley   +1 more source

Safety of the proposed amendment of the specifications of the food additive E960c(i) or E960c(ii). [PDF]

open access: yesEFSA J
EFSA Panel on Food Additives and Flavourings (FAF)   +32 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy